HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin D status is associated with hepcidin and hemoglobin concentrations in patients with severe traumatic injury.

AbstractBACKGROUND:
Severe traumatic injury leads to persistent injury-associated anemia that is associated with hypercatecholaminemia, systemic inflammation, increased hepcidin, and a functional iron deficiency. Vitamin D has been shown to reduce proinflammatory cytokines and hepcidin concentrations. This study aimed to investigate the association of vitamin D status with inflammation, iron biomarkers, and anemia following blunt trauma.
METHODS:
A prospective observational cohort study comparing blunt trauma patients (n = 45) with elective hip replacement patients (n = 22) and healthy controls (n = 8) was performed. Bone marrow ferroportin, transferrin receptor, and erythroferrone expression was measured using quantitative polymerase chain reaction (qPCR). Plasma was assessed for systemic inflammation, erythropoietin (EPO), iron regulation, and vitamin D (25-OH) concentrations using enzyme-linked immunosorbent assay. Hemoglobin was measured on the day of discharge.
RESULTS:
Compared with hip replacement, trauma patients had higher plasma interleukin-6 (90.1 vs. 3.8 pg/mL), C-reactive protein (6,223 vs. 2,612 ng/mL), and hepcidin (79.3 vs. 21.2 ng/mL) concentrations. Trauma patients had lower vitamin D (25-OH) (12.8 vs. 18.1 ng/mL) and iron (23.5 vs. 59.9 μg/mL) levels compared with hip replacement patients. Despite the higher hepcidin EPO levels, bone marrow erythroferrone expression was increased 69% following trauma.
CONCLUSION:
Following elective hip replacement, patients did have anemia and impaired iron homeostasis without a significant change in inflammatory biomarkers, EPO, and vitamin D status. Vitamin D status did correlate with systemic inflammation, iron dysfunction, and persistent injury-associated anemia following severe blunt trauma. Further research is needed to determine whether supplementation with vitamin D in the trauma population could improve the persistent injury-associated anemia.
LEVEL OF EVIDENCE:
Prospective study, prognostic, level III.
AuthorsCamille G Apple, Elizabeth S Miller, Kolenkode B Kannan, Julie A Stortz, Michael Cox, Tyler J Loftus, Hari K Parvataneni, Matthew Patrick, Jennifer E Hagen, Scott Brakenridge, Philip A Efron, Alicia M Mohr
JournalThe journal of trauma and acute care surgery (J Trauma Acute Care Surg) Vol. 89 Issue 6 Pg. 1124-1130 (12 2020) ISSN: 2163-0763 [Electronic] United States
PMID32769953 (Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural)
Chemical References
  • Biomarkers
  • EPO protein, human
  • Hemoglobins
  • Hepcidins
  • Erythropoietin
  • Vitamin D
  • C-Reactive Protein
  • Iron
Topics
  • Adult
  • Anemia, Iron-Deficiency (etiology)
  • Biomarkers (blood)
  • C-Reactive Protein (analysis)
  • Erythropoietin (blood)
  • Female
  • Hemoglobins (analysis)
  • Hepcidins (blood)
  • Humans
  • Iron (blood)
  • Male
  • Middle Aged
  • Prospective Studies
  • Vitamin D (blood)
  • Vitamin D Deficiency (etiology)
  • Wounds, Nonpenetrating (blood, complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: